Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma prophylaxis Age: Adult Condition: Mild asthma |
Dose: Powder or aerosol inhaler – 100 mcg Frequency: twice daily |
|
Indication: Asthma prophylaxis Age: Adult Condition: Severe asthma |
Dose: Powder or aerosol inhaler – up to 500-1,000 mcg Frequency: twice daily |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma prophylaxis Age: 4-16 years |
Dose: Powder or aerosol inhaler – 50-100 micrograms Frequency: twice daily Note: Increased to 200 micrograms twice daily if necessary |
|
Indication: Asthma prophylaxis Age: less than 4 years |
Dose: Powder or aerosol inhaler – Not established Note: Safety and efficacy not established |
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
| Disease Name | Risk Factors |
|---|---|
|
Drug/Milk Protein Hypersensitivity
|
Risk of severe allergic reaction
|
|
Status Asthmaticus
|
Not for primary treatment
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.